Chemours turns to euros as it reprices $1.5bn term loan 'B'

Chemours, the listed US chemicals firm spun out of DuPont in 2015, held a lender call on Monday afternoon for a $350m-equivalent euro term loan to repay some of its existing dollar loan.

  • By Max Bower
  • 20 Mar 2017

The Wilmington, Delaware-based firm also wants to reprice its $1.5bn seven year term loan ‘B’, signed in 2015, after its $3bn spin-out from DuPont. The original margin was 300bp with a 0.75% Libor floor.

Price talk for the dollar repricing of 250bp with a 0% floor was released after ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bookrunners of European Leveraged Loans

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 16,081.88 63 6.99%
2 BNP Paribas 14,608.34 81 6.35%
3 Goldman Sachs 13,180.95 51 5.73%
4 HSBC 12,272.28 75 5.33%
5 Deutsche Bank 11,710.26 65 5.09%

Bookrunners of European HY Bonds

Rank Lead Manager Amount €m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 5,442.63 45 7.89%
2 Goldman Sachs 4,801.82 38 6.96%
3 Deutsche Bank 4,751.46 46 6.89%
4 Credit Suisse 4,353.57 48 6.31%
5 Barclays 4,263.74 37 6.18%

Bookrunners of Dollar Denominated HY Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 28,018.08 214 10.92%
2 Bank of America Merrill Lynch 21,116.58 187 8.23%
3 Citi 21,099.90 168 8.23%
4 Goldman Sachs 19,427.53 135 7.58%
5 Barclays 17,943.05 119 7.00%